Literature DB >> 26099307

Common Aging Signature in the Peripheral Blood of Vascular Dementia and Alzheimer's Disease.

Hongbo Luo1, Guangchun Han2, Jiajia Wang2,3, Fan Zeng4, Yuanming Li1, Shaoju Shao1, Fuhai Song2,3, Zhouxian Bai2,3, Xing Peng2,3, Yan-Jiang Wang4, Xiangqun Shi5, Hongxing Lei6,7.   

Abstract

Alzheimer's disease (AD) and vascular dementia (VaD) are the two most dominant forms of dementia in elderly people. Due to the large overlap between AD and VaD in clinical observations, great controversies exist regarding the distinction and connection between these two types of senile dementia. Here for the first time, we resort to the gene expression pattern of the peripheral blood to compare AD and VaD objectively. In our previous work, we have demonstrated that the dysregulation of gene expression in AD is unique among the examined diseases including neurological diseases, cancer, and metabolic diseases. In this study, we found that the dysregulation of gene expression in AD and VaD is quite similar to each other at both functional and gene levels. Interestingly, the dysregulation started at the early stages of the diseases, namely mild cognitive impairment (MCI) and vascular cognitive impairment (VCI). We have also shown that this signature is distinctive from that of peripheral vascular diseases. Comparison with aging studies revealed that the most profound change in AD and VaD, namely ribosome, is consistent with the accelerated aging scenario. This study may have implications to the common mechanism between AD and VaD.

Entities:  

Keywords:  Alzheimer’s disease; Gene expression; Peripheral blood; Ribosome; Vascular dementia

Mesh:

Substances:

Year:  2015        PMID: 26099307     DOI: 10.1007/s12035-015-9288-x

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  50 in total

Review 1.  Similarities between Alzheimer's disease and vascular dementia.

Authors:  Raj Kalaria
Journal:  J Neurol Sci       Date:  2002-11-15       Impact factor: 3.181

2.  Whole blood gene expression analyses in patients with single versus recurrent venous thromboembolism.

Authors:  Deborah A Lewis; Gregg J Stashenko; Olga M Akay; Lulit I Price; Kouros Owzar; Geoffrey S Ginsburg; Jen-Tsan Chi; Thomas L Ortel
Journal:  Thromb Res       Date:  2011-07-07       Impact factor: 3.944

Review 3.  [Cognitive function and basic activity of daily living of elderly disabled inpatients].

Authors:  Y Minemawari; T Kato; K Aso
Journal:  Nihon Ronen Igakkai Zasshi       Date:  2000-03

4.  Human aging is characterized by focused changes in gene expression and deregulation of alternative splicing.

Authors:  Lorna W Harries; Dena Hernandez; William Henley; Andrew R Wood; Alice C Holly; Rachel M Bradley-Smith; Hanieh Yaghootkar; Ambarish Dutta; Anna Murray; Timothy M Frayling; Jack M Guralnik; Stefania Bandinelli; Andrew Singleton; Luigi Ferrucci; David Melzer
Journal:  Aging Cell       Date:  2011-07-19       Impact factor: 9.304

5.  Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database.

Authors:  Sid E O'Bryant; Laura H Lacritz; James Hall; Stephen C Waring; Wenyaw Chan; Zeina G Khodr; Paul J Massman; Valerie Hobson; C Munro Cullum
Journal:  Arch Neurol       Date:  2010-06

6.  Quantitative evaluation of the rRNA in Alzheimer's disease.

Authors:  A M da Silva; S L Payão; B Borsatto; P H Bertolucci; M A Smith
Journal:  Mech Ageing Dev       Date:  2000-12-01       Impact factor: 5.432

7.  Toward an Alzheimer's disease diagnosis via high-resolution blood gene expression.

Authors:  Pascale Fehlbaum-Beurdeley; Anne Charlotte Jarrige-Le Prado; Diego Pallares; Jennifer Carrière; Caroline Guihal; Cyril Soucaille; Fabien Rouet; Dominique Drouin; Olivier Sol; Heather Jordan; Darong Wu; Ling Lei; Richard Einstein; Fabien Schweighoffer; Laurent Bracco
Journal:  Alzheimers Dement       Date:  2010-01       Impact factor: 21.566

8.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

9.  Serum S100A12 concentrations are correlated with angiographic coronary lesion complexity in patients with coronary artery disease.

Authors:  Jun Liu; Yin-Gang Ren; Li-Hua Zhang; Ya-Wen Tong; Li Kang
Journal:  Scand J Clin Lab Invest       Date:  2013-12-16       Impact factor: 1.713

10.  Meta-analysis on blood transcriptomic studies identifies consistently coexpressed protein-protein interaction modules as robust markers of human aging.

Authors:  Erik B van den Akker; Willemijn M Passtoors; Rick Jansen; Erik W van Zwet; Jelle J Goeman; Marc Hulsman; Valur Emilsson; Markus Perola; Gonneke Willemsen; Brenda W J H Penninx; Bas T Heijmans; Andrea B Maier; Dorret I Boomsma; Joost N Kok; Pieternella E Slagboom; Marcel J T Reinders; Marian Beekman
Journal:  Aging Cell       Date:  2013-11-19       Impact factor: 9.304

View more
  6 in total

1.  Screening of Human Circular RNAs as Biomarkers for Early Onset Detection of Alzheimer's Disease.

Authors:  Da Zheng; Rana Adnan Tahir; Yan Yan; Juan Zhao; Zhenzhen Quan; Guixia Kang; Ying Han; Hong Qing
Journal:  Front Neurosci       Date:  2022-07-05       Impact factor: 5.152

2.  Genetic heterogeneity of Alzheimer's disease in subjects with and without hypertension.

Authors:  Alireza Nazarian; Konstantin G Arbeev; Arseniy P Yashkin; Alexander M Kulminski
Journal:  Geroscience       Date:  2019-05-05       Impact factor: 7.713

3.  The frontline of immune response in peripheral blood.

Authors:  Fuhai Song; Ying Qian; Xing Peng; Xiuhui Li; Peiqi Xing; Dongqing Ye; Hongxing Lei
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

4.  Addition of Aβ42 to Total Cerebral Small Vessel Disease Score Improves the Prediction for Cognitive Impairment in Cerebral Small Vessel Disease Patients.

Authors:  Jianping Liu; Weihua Zhao; Qinghong Gui; Ying Zhang; Zaiyu Guo; Wei Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2021-01-25       Impact factor: 2.570

Review 5.  Towards Personalized Intervention for Alzheimer's Disease.

Authors:  Xing Peng; Peiqi Xing; Xiuhui Li; Ying Qian; Fuhai Song; Zhouxian Bai; Guangchun Han; Hongxing Lei
Journal:  Genomics Proteomics Bioinformatics       Date:  2016-09-28       Impact factor: 7.691

6.  Multi-omics signature of brain amyloid deposition in asymptomatic individuals at-risk for Alzheimer's disease: The INSIGHT-preAD study.

Authors:  Laura Xicota; Farid Ichou; François-Xavier Lejeune; Benoit Colsch; Arthur Tenenhaus; Inka Leroy; Gaëlle Fontaine; Marie Lhomme; Hugo Bertin; Marie-Odile Habert; Stéphane Epelbaum; Bruno Dubois; Fanny Mochel; Marie-Claude Potier
Journal:  EBioMedicine       Date:  2019-09-03       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.